Saturday
Enjoy two hour, in-depth discussions on specific topics. These non-microscopic workshops emphasize interaction in small groups.
Friday | Saturday | Sunday | Tuesday
| Saturday, November 5, 2011 |
8:00 am - 9:30 am
 | Cytology Workshop #3
Credit Hours:1.5 CME/CMLE/SAM
Advances in Pulmonary Cytology: Doing More with Less
Jennifer A. Brainard, MD
Christine N. Booth, MD
+Show/Hide Description
Educational Objectives:
1. Apply a systematic approach to diagnostic challenges in pulmonary cytology encountered in daily practice
2. Identify the applications and limitations of special techniques and molecular markers relevant to pulmonary cytopathology
3. Understand the clinical significance of pulmonary cytopathologic diagnoses
Lung carcinoma is the leading cause of cancer mortality for both genders in the United States and throughout the world. Cytologic techniques are usually part of the initial workup of patients with suspected pulmonary malignancy and are commonly used for both diagnosis and staging. On-site assessment of specimen adequacy together with cytomorphologic features and use of ancillary techniques including immunostaining profiles and flow cytometry make this possible in most cases. Additionally, in the past, a cytologic diagnosis of small cell carcinoma versus non-small cell carcinoma was sufficient to appropriately direct patient management. However, with recent advances in molecular medicine and the clinical use of selective EGFR tyrosine kinase inhibitors, it has become increasingly important to specifically classify non-small cell carcinomas in cytologic preparations. Immunostaining patterns are quite useful in this regard. The course faculty will use a case-based approach to illustrate diagnostically challenging pulmonary neoplasms in which a combination of morphology and ancillary testing was used to make a definitive interpretation. Distinguishing specific subtypes of non-small cell carcinoma and the role of EGFR testing will be emphasized.
|
8:00 am - 9:30 am
 | Cytology Workshop #4
Credit Hours:1.5 CME/CMLE/SAM
Integration of Molecular Ancillary Techniques Into Routine Cytology Practice: Issues in Current State of the Art and Critical Future Trends
Stewart M. Knoepp, MD, PhD
Michael H. Roh, MD, PhD
+Show/Hide Description
Educational Objectives:
1. To review select examples of molecular techniques routinely requested on cytologic specimens, and consider additional techniques likely to be increasingly utilized in the future
2. To discuss the advantages and disadvantages of various platforms (e.g., cell blocks, direct smears, Whatman cards, frozen specimens) with which ancillary studies are performed
3. To discuss optimal triage of limited cytologic specimens for performing diagnostic and prognostic ancillary studies by leveraging the available diversity of cytologic material
We plan to discuss scenarios where molecular analytic tools play vital roles in rendering specific cytologic diagnoses as well as providing key therapeutic and prognostic information. Information provided will be based on interactions with oncologists, a large state of the art pathology molecular testing facility, as well as extensive literature review. Examples include subclassification of non-small cell carcinoma, EGFR mutational analysis in pulmonary adenocarcinoma, mutational analysis of thyroid neoplasms, cytogenetic analysis of small round blue cell tumors, and optimal identification of lymphoid neoplasms. We will then poll the audience as to the platforms used for these ancillary studies in their routine practices. Results from the poll will provide a segue into discussing advantages and disadvantages of these platforms, incorporating personal laboratory and research experience, recent publications, and a thorough up-to-date literature review. Finally, we will present a holistic, integrated approach for triaging limited cytologic tissue in the laboratory aimed at optimizing both cytologic diagnoses as well as the performance of clinically relevant ancillary studies. Optimal triage will be predicated on the appropriate clinico-pathologic contexts and ensuing molecular techniques to be performed (e.g., PCR-based mutational analysis, fluorescence in situ hybridization, signal amplification techniques, chromogenic in situ hybridization) as well as the necessity of traditional immunocytochemistry. The advantages and disadvantages of immunocytochemical techniques performed on cell blocks and direct smears will also be discussed.
|
8:00 am - 9:30 am
 | Cytology Workshop #5
Credit Hours:1.5 CME/CMLE/SAM
Renal FNA in the Age of Nephron Sparing Treatment of Renal Tumors
Gladwyn Leiman, MBBCh, FIAC, FRCPath
Scott R. Anderson, MD
+Show/Hide Description
Educational Objectives:
1. To provide an updated overview of current diagnosis and management of renal masses, particularly those small and asymptomatic lesions detected incidentally during imaging of the upper abdomen. The resurgent importance of renal FNA as an ideal tool for diagnosis prior to cryotherapy, radio-frequency ablation and nephron-sparing surgery will be emphasized
2. To outline the FNA morphology of benign elements which may frequently contaminate the sampling of small neoplastic nodules, and which may mimic well-differentiated tumors
3. To acquaint participants with the many faces of benign and malignant renal neoplasms, demonstrating examples of common and uncommon tumor types and their prognosis. Cases will be drawn from 10 years experience with renal tumor FNAs in Vermont. Particular emphasis will be focused on the diagnosis and differential diagnosis of benign, borderline and low metastatic potential renal tumors, with histological correlation
4. To disseminate a working protocol of adjunctive immunotests which will assist in differential diagnosis if required
This Cytopathology Workshop is aimed at cytopathologists and cytotechnologists involved in the on-site collection and rapid interpretation of renal FNAs, often performed at the commencement of interventional cryotherapy and radio-frequency procedures in order to obtain confirmation of cell type prior to ablation of small renal masses. The re-emergence of renal FNA as the diagnostic tool of choice in these situations will be discussed, with statistical analysis of results which may be expected. The major focus of the workshop will be on morphologic identification of benign renal elements, benign tumors, low metastatic potential and well-differentiated tumors, which are encountered preferentially in the setting of incidentally discovered small renal masses. Pitfalls in diagnosis will be illustrated, together with an outline of a working immunocytochemistry protocol which can assist in differential diagnostic challenges.
|